Publisher Correction: B cell therapy in ANCA-associated vasculitis: current and emerging treatment options.
In the section 'Combining B cell-targeted therapies' in the originally published version of this article, the 24-week interim analysis for the CALIBRATE study was incorrectly given as the 2- to 4-week interim analysis. This error has now been corrected in the HTML and PDF versions of the manuscript.
| Publicado en: | Nature Reviews Rheumatology Vol. 14; no. 12; pp. 741 - 742 |
|---|---|
| Autores principales: | , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Sumario: | In the section 'Combining B cell-targeted therapies' in the originally published version of this article, the 24-week interim analysis for the CALIBRATE study was incorrectly given as the 2- to 4-week interim analysis. This error has now been corrected in the HTML and PDF versions of the manuscript. |
|---|